Delivery Order V797P5828X-V614A01413

Award Date 4/21/10
Potential Completion Date 7/2/10
Potential Value $38K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Memphis, TN 38104, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order issued by the Food and Drug Administration (FDA), a civilian federal agency, under the Information Technology Schedule 70 (IT-70) contract vehicle. The order, awarded to ICF Esac, LLC, a subsidiary of ICF International, Inc., is for the enhancement and maintenance of the Individual Case Safety Report (ICSR) system. The order has a ceiling value of $129,036.62 and is a labor-hours contract type, with no set-aside designation. ICF Esac, LLC has experience providing...
��������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������...
This is a delivery order award under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $35,378.29, is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product. The award has a completion date of February 25, 2025 and utilizes a Firm Fixed Price pricing type. AmerisourceBergen Drug Corp is the prime contractor for this award, which does not have a set-aside...
This federal contract award is for an "EXPRESS REPORT: IMPLANT" valued at $46,128.00. The contract was awarded to Abbott Laboratories Inc., a large pharmaceutical and medical device manufacturer, through its Abbott Vascular Inc. division. The contract is a firm fixed-price purchase order with a completion date of October 31, 2024. The contract was awarded by the Veterans Integrated Service Network 17, a division of the Department of Veterans Affairs (VA). This suggests the contract...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency (DHA) to Central Admixture Pharmacy Services, Inc. (doing business as Caps), a for-profit organization specializing in compounded sterile pharmaceutical preparations. The contract, valued at $250,000.00, is for CAPS COMPOUNDED PRESENTATIONS and does not have a set-aside designation. Central Admixture Pharmacy Services, Inc. has multiple Indefinite Delivery Vehicles (IDVs) with federal...
This federal contract award, with an ID of SPE2DB22D3004|SPE2DB25FPX52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a ceiling value of $1,267.11, is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a medical product used in the treatment of diabetes. The contract is a Firm Fixed Price Delivery Order, with a period of performance ending on March 17, 2025....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $8,179.85, is for the delivery of NovoSeven RT 1 mg vials, a specialized pharmaceutical product. The contract has an ultimate completion date of February 24, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded...
This federal contract award, identified as SPE2DB24D1007|SPE2DB25FCARR, was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,139.98, is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Starlims Corporation, doing business as Abbott Informatics Corp, a foreign-owned, for-profit organization. The contract, valued at $447,982.00, is for the provision of sample management software for the agency's Domestic Preparedness Activity (DPA). This contract does not have a set-aside designation. Starlims Corporation, a subsidiary of the parent company Abbott Laboratories Inc., is an...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceutical products. The order has a ceiling value of $2,983.28 and a period of performance that extends through November 18, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC...
  • V797P5828X
    Federal Supply Schedule
  • V797P5828X-V614A01413
    Delivery Order

EXPRESS REPORT - IFCAP TO FPDS-NG REJECTS NOVO SEVEN INJECTION

Posted 4/21/10, 12:00 AM